The Community as a Place of Prevention

Community medicine brings clinical knowledge into the settings where people live, gather, and develop relationships. Churches, cultural organizations, and community service centers can provide opportunities to reach people who might not otherwise seek a particular preventive service.

This does not mean that everyone attending a community screening event lacks healthcare. Some have regular physicians and established access to care. Others face language, insurance, scheduling, or transportation difficulties. Even people who routinely use medical services may never have discussed the risk being addressed.

The community offers a different starting point. Participation can begin with an explanation from a familiar organization, an announcement in a preferred language, or a conversation at a local event. These encounters can bring prevention into view before symptoms prompt a medical visit.

They can also generate evidence that is difficult to obtain from clinical records alone. Community-based research can examine who participates, how people understand an offer of testing, and what happens when an identified need must be connected to the healthcare system.

Such research has limitations of its own. Participants recruited through community networks may differ from those who are less connected or less inclined to volunteer. Community data should therefore complement institutional research. Together, they can provide a fuller picture of disease and the delivery of care.

Why H. pylori Is an Important Example

H. pylori is a bacterial infection of the stomach and a major modifiable contributor to noncardia gastric cancer. Infection is often acquired in childhood and may persist for years without obvious symptoms. Eradication can reduce subsequent cancer risk, although it does not necessarily remove the risk associated with established gastric atrophy or intestinal metaplasia.

For immigrants from regions with a substantial gastric cancer burden, earlier infection may remain relevant long after relocation. Yet testing may occur only when symptoms develop or when a clinician recognizes an increased risk.

This creates a practical prevention challenge. There is a medically actionable infection, a noninvasive means of detecting it, and treatment that can clear it. What is less consistently established is a pathway that helps people move through all the necessary steps.

The sequence extends beyond screening: receiving and understanding the result, obtaining clinical evaluation, accessing medication, completing treatment, and undergoing testing to confirm eradication. A program that measures only how many people were tested may miss much of what determines its eventual benefit.

Building the Program Together

The Yale–KCS collaboration brought screening to 17 community sites serving Korean American populations. Between June and November 2025, 323 Korean-born adults completed screening and survey procedures.

Events were organized with community service organizations, churches, and cultural groups. Outreach used Korean-language and bilingual materials, local announcements, partner networks, and community communication channels. Participants completed a questionnaire and an on-site urea breath test, which detects active infection.

The partnership involved more than providing a venue. Community organizations helped shape event logistics, language needs, and how the purpose of the program was explained. Bilingual research staff, navigators, community workers, and volunteers supported participation and continuing engagement.

Their contribution deserves explicit recognition. Clinical expertise can establish what should be offered. Community expertise helps determine how an offer can be understood, accepted, and followed through.

A resource guide becomes useful when it identifies care that participants can realistically access. A test result becomes actionable when someone explains its meaning in a language the participant understands. Follow-up becomes possible when staff maintain contact respectfully and respond to practical questions as they arise.

These functions are part of the intervention itself.

What Happened After Screening?

Active H. pylori infection was identified in 58 of the 323 participants, or approximately 18%. All 58 were successfully contacted for confidential result disclosure and counseling.

That was an important accomplishment: every participant with detected infection received an explanation and an opportunity for assistance. Subsequent progress, however, was less complete.

During follow-up of up to six months, 31 participants reported completing a clinical evaluation, 15 completed eradication therapy, and nine underwent post-treatment testing. Eight of the nine retested participants had confirmed eradication.

The difference between successful disclosure and completed care is the central observation. Contacting someone and explaining a positive result did not automatically lead to an appointment, treatment, and confirmation of cure.

These figures should not be interpreted as final outcomes for everyone. Some participants remained engaged with navigators but had not completed later steps by the end of observation. An appointment could still be pending, treatment could be delayed, or retesting might not yet have occurred. The study captured progress within a defined period, rather than a permanent division between those who completed care and those who never would.

Nor can the eight successful eradications among nine retested participants establish treatment effectiveness for the entire infected group. They show what was documented in a small subgroup that reached the final stage.

The findings are most informative as a description of the work between screening and completed care.

The Distance Between a Result and Care

A positive test creates a medical recommendation, but acting on it requires a series of practical arrangements.

Participants may need to determine where to seek care, whether insurance covers the visit or testing, how to obtain an appointment, and how to manage transportation or time away from other responsibilities. Prescription access and medication tolerance can introduce additional difficulties. After treatment, arranging a separate test may require another encounter with the system.

The program documented barriers involving insurance, appointment availability, transportation, prescription access, and post-treatment testing. Each may appear modest in isolation. Across several steps, however, they can slow or interrupt care.

It would be easy to describe incomplete follow-up simply as a lack of adherence. That interpretation can overlook the circumstances in which participants are trying to obtain care. Continued navigator contact helped make some of those circumstances visible.

Navigation included explanations, bilingual materials, laboratory reports, clinician letters, information about local providers and safety-net services, and repeated follow-up. Its purpose was to help participants connect
a community screening result with clinical care.

This also shows why navigation requires sustained resources. The work continues after an event has ended and may extend across several months. It involves maintaining records, answering questions, identifying unfinished steps, and coordinating across organizations with different responsibilities.

Community Work Is Also Research

Community-based research connects a biological question—does someone have an infection?—with a delivery question—can that person obtain and complete the care it calls for?

Both are necessary. A prevalence study helps define the size and distribution of a problem. An implementation study examines how a response functions in practice. Following participants beyond testing revealed where progress slowed and where additional support might be needed.

The collaboration also illustrates a productive relationship between academic medicine and community organizations. Academic teams bring research methods and clinical knowledge. Community partners bring local experience, communication skills, established relationships, and an understanding of barriers that may not be obvious from within a medical center.

Working together allows those perspectives to inform both the service and its evaluation. It also recognizes community workers and volunteers as contributors to knowledge. Their observations and continuing contact can help explain why a medically appropriate recommendation has not yet become completed care.

The model should not be assumed to work identically everywhere. Other populations may have different languages, healthcare arrangements, community networks, and preferences. The useful question is which functions should be preserved—accessible engagement, understandable communication, and continuing assistance—and how they can be delivered locally.

What This Early Project Can Teach Us

This was a descriptive evaluation of an early program. Participants were volunteers recruited through community settings, not a representative sample of all Korean Americans. There was no comparison group, so the effect of navigation could not be isolated. Later outcomes relied on participant reports and navigator documentation rather than systematic medical-record verification. Follow-up was limited, and gastric cancer outcomes were not measured.

These limitations define what the project can claim. It demonstrates that screening and confidential result communication could be delivered through this partnership, and it describes the challenges encountered afterward. It does not establish population-wide infection prevalence, prove that navigation improved outcomes, or show that the program reduced cancer incidence.

Nonetheless, it identifies questions worth pursuing. How can appointments and prescriptions become easier to obtain? What arrangements improve access to retesting? Which forms of navigation are most useful? What resources allow community organizations to sustain this work?

Those questions extend beyond gastric cancer prevention. Many preventive services require people to move between community settings, primary care, laboratories, pharmacies, and specialist services. The strength of a recommendation matters, but so does the ability to complete that journey.

Community medicine makes that journey visible. It reminds us that prevention is delivered through relationships, communication, and practical support as well as tests and treatments. To understand whether medical knowledge is improving health, we need to follow it beyond the clinic—and learn from the people doing that work in the community.